Gyre Therapeutics, Inc. (GYRE) Earnings
NASDAQ·Healthcare·Biotechnology
$7.70
+0.85%
Mkt Cap $679.38M
Next Earnings
In 8 daysThu, May 7, 2026
EPS Estimate
-$0.06
2 analysts
Revenue Estimate
$31.61M
Last quarter: missed by -29.42% on EPS, +4.97% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$679.38M
P/E
337.78
Fwd P/E
47.82
P/S
5.83
Rev TTM
—
EPS TTM
$0.02